Tenth Annual NYU Langone Advanced Seminar in Psoriasis and Psoriatic Arthritis

  13 Dec 2024 - 13 Dec 2024

   New York, NY, United States

conference-img

Tenth Annual NYU Langone Advanced Seminar in Psoriasis and Psoriatic Arthritis

13 Dec 2024

 - 

13 Dec 2024

New York, NY, United States



The course will review and address those areas where recent, solid knowledge in the basic science, translational, and clinical aspects of psoriasis, psoriatic arthritis, and related conditions is available, focusing particularly on the state-of-the-art in the field, at the leading edge between new basic and clinical knowledge and its translation into practice.

Lectures and Year-In-Review updates will provide participants with the latest information in psoriasis, psoriatic arthritis and other related conditions. Participants will have the opportunity to raise questions and participate in dialogue with the course instructors and clinical experts.

SGO Annual Meeting on Women’s Cancer 2026

On: 10 Apr 2026

-

13 Apr 2026


AACR Oncology Industry Partnering Event: From Cancer Discoveries to Patients

On: 16 Apr 2026

-

17 Apr 2026


AACR Annual Meeting 2026

On: 17 Apr 2026

-

22 Apr 2026


Thriving Together: 2026 Conference on Metastatic Breast Cancer

On: 17 Apr 2026

-

19 Apr 2026


Global Conference on Orthopedic Surgery and Trauma Care

On: 01 May 2026

-

01 May 2026


SGO Annual Meeting on Women’s Cancer 2026

On: 10 Apr 2026

-

13 Apr 2026


AACR Oncology Industry Partnering Event: From Cancer Discoveries to Patients

On: 16 Apr 2026

-

17 Apr 2026


AACR Annual Meeting 2026

On: 17 Apr 2026

-

22 Apr 2026


Thriving Together: 2026 Conference on Metastatic Breast Cancer

On: 17 Apr 2026

-

19 Apr 2026


Global Conference on Orthopedic Surgery and Trauma Care

On: 01 May 2026

-

01 May 2026



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Studies have shown that physical activity prevents cancer in patients who have been treated for cancer in the past.

2.

After targeted agents, a novel bispecific in EGFR-mutant lung cancer improves PFS.

3.

In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.

4.

A specific drug combination is being tested in a clinical trial for the deadly brain cancer glioblastoma.

5.

In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot